In a 9-6 vote, an advisory panel said the FDA should not yet approve dapagliflozin, a new type of diabetes drug that makes the body dump sugar and lose weight. Signals of possible cancer and liver damage worried the experts.
See more here:
FDA Panel Opposes New Type of Diabetes Drug
The Center for Science in the Public Interest has announced winners of the Xtreme Eating Awards – restaurant foods that have the most calories.
Here is the original:
Restaurant Foods Win ‘Awards’ for Most Calories
Safety concerns led an FDA advisory panel to oppose approval of a new drug for gout, despite widespread enthusiasm for the medication’s effectiveness against the painful disorder.
Go here to read the rest:
FDA Panel Rejects Gout Drug on Safety Concerns
Categories: General News Tags: advisory-panel, against-the-painful, concerns-led, Fda, gout-pain, hands-experiencing, medication, new-drug, oppose-approval, painful, the-medication
Specific drugs used to treat inflammatory diseases like rheumatoid arthritis (RA) and psoriasis may also help protect patients with these conditions from developing type 2 diabetes, a study shows.
Read more here:
Some RA Drugs May Lower Diabetes Risk
Categories: General News Tags: advisory-panel, against-the-painful, concerns-led, drugs-used, gout-pain, hands-experiencing, help-protect, medication, new-drug, oppose-approval, painful, Rheumatoid Arthritis, the-medication, these-conditions, treat-inflammatory
Recent Comments